Organogenesis Holdings is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical and Sports Medicine markets. In the Advanced Wound Care market, Co. focuses on the development and commercialization of a portfolio of cellular and acellular wound care offerings that treat patients from the earliest indication of impaired healing to wound closure. In the Surgical and Sports Medicine market, Co. focuses on the development and commercialization of products that support the healing of musculoskeletal injuries, including chronic degenerative conditions such as osteoarthritis and tendonitis. The ORGO stock yearly return is shown above.
The yearly return on the ORGO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ORGO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|